Compare Barclays PLC (BCS) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Barclays PLC vs Smith & Nephew plc — how do they compare? Barclays PLC trades at $28.1 (market cap $94.10B), while Smith & Nephew plc trades at $30.05 (market cap $12.50B). The key difference: Barclays PLC is far larger — about 7.5× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.64%). Which is the better fit depends on your goals.
| BCS | SNN | |
|---|---|---|
Market Cap | $94.10B | $12.50B |
Sector | Financials | Health |
52-Week High | $28.56 | $38.70 |
52-Week Low | $19.36 | $28.73 |
Dividend Yield | 2.18% | 2.64% |
Enterprise Value | — | $15.53B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Barclays PLC
Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments
Read more on BCS →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
